The collaboration brings together IROS’s clinical research expertise with BioSapien’s innovative cancer treatment technology to advance precision medicine in the region.
The management contract forms part of Seha Group’s broader expansion strategy, which emphasizes development and operational excellence rather than traditional acquisition models.
The forum aimed to strengthen the UAE’s position as a premier regional hub for clinical research while demonstrating the nation’s dedication to building a healthcare ecosystem driven by knowledge and innovation.
The partnership will begin with a study focused on assessing Mirai’s ability to predict breast cancer risk specifically in Japanese women using mammography images.
Currently operating 15 hospitals across the GCC, Aster DM Healthcare continues to drive healthcare excellence by expanding centers of excellence, incorporating advanced diagnostic technologies, and implementing best-practice medical protocols within its network.
Saltzman, 75, co-founded Dis-Chem with his wife, Lynette, in 1978 and has played a central role in transforming the business from a family-run operation into a national chain.
Morocco’s pledge is timely, as Gavi prepares to implement its next strategic phase, known as “Gavi 6.0,” which aims to protect 500 million children between 2026 and 2030
The Zambia Medicines Regulatory Authority (ZAMRA) granted approval on November 4, 2025, completing its review in just 12 working days through an innovative regulatory pathway.
Experts project that up to 700 million people could inhabit areas vulnerable to Lassa fever by 2070.
The agreement emerged from the Blue-Sky Visioning and Think Tank Workshop held in Johannesburg from November 25 to 27, 2025.